Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adenosylmethionine decarboxylase 1 pseudogene is an inactive genomic sequence that closely resembles the **AMD1 gene**, which encodes a key enzyme in polyamine biosynthesis. Unlike the functional AMD1 gene, this pseudogene contains sequence interruptions such as frameshifts or premature stop codons and does not produce a functional protein. Pseudogenes are typically categorized as nonfunctional DNA, but may sometimes have regulatory roles at the RNA level. The presence of this pseudogene indicates evolutionary duplication and mutational inactivation of the original AMD1 gene, but it is not considered a valid therapeutic target or biomarker[2][5].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosylmethionine decarboxylase 1 pseudogene (null).